FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Overview Fund Activity
Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

21 hedge funds and large institutions have $14.1M invested in F-star Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 16 reducing their positions, and 7 closing their positions.

Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
5
Increased
–
Reduced
16
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AVA
1
Atlas Venture Advisors
Massachusetts
$5.68M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.83M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.79M
4
NHAS
4
Novo Holdings A/S
Denmark
$344K
5
ECM
5
Endurant Capital Management
California
$202K

Top Sellers

1
BI
1
BVF Inc
California
$255K
2
BlackRock
2
BlackRock
New York
$443K
3
TA
3
Tiedemann Advisors
New York
$170K
4
Morgan Stanley
4
Morgan Stanley
New York
$47K
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
– – -6,212 Closed
GT
27
Glenmede Trust
Pennsylvania
– – -4,200 Closed
Wells Fargo
28
Wells Fargo
California
$0 24 -73 -75%
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2